Key statistics
As of last trade, Shield Therapeutics PLC (1JS:FRA) traded at 0.031, 226.32% above the 52 week low of 0.0095 set on Apr 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.031 |
---|---|
High | 0.031 |
Low | 0.031 |
Bid | 0.0285 |
Offer | 0.0355 |
Previous close | 0.0305 |
Average volume | 355.56 |
---|---|
Shares outstanding | 782.06m |
Free float | 295.94m |
P/E (TTM) | -- |
Market cap | 20.72m GBP |
EPS (TTM) | -0.0477 GBP |
Data delayed at least 15 minutes, as of Nov 13 2024 07:08 GMT.
More ▼
Announcements
- Q3 Trading Update
- Results from Phase 3 paediatric study
- Interim results
- ACCRUFeR® Approved by Health Canada
- Notice of interim results
- Unaudited Q2 2024 Trading Update
- Directorate Change
- $5.7m Milestone Monetization Agreement with AOP
- Results of 2024 Annual General Meeting
- New Drug Application for Accrufer® in South Korea
More ▼